These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31840560)

  • 1. Advances in delivery vectors for gene therapy in liver cancer.
    Redd Bowman KE; Lu P; Vander Mause ER; Lim CS
    Ther Deliv; 2020 Jan; 11(1):833-850. PubMed ID: 31840560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of gene therapy for hepatocellular carcinoma, with a focus on gene delivery approaches.
    Wang X; Tai Z; Zhang W; Gao S
    Curr Gene Ther; 2015; 15(2):120-41. PubMed ID: 25537775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in liver-directed gene therapy for hepatocellular carcinoma by non-viral delivery systems.
    Ding B; Li T; Zhang J; Zhao L; Zhai G
    Curr Gene Ther; 2012 Apr; 12(2):92-102. PubMed ID: 22348553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma.
    Dhungel B; Jayachandran A; Layton CJ; Steel JC
    Drug Deliv; 2017 Nov; 24(1):289-299. PubMed ID: 28165834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma.
    Wang YG; Huang PP; Zhang R; Ma BY; Zhou XM; Sun YF
    World J Gastroenterol; 2016 Jan; 22(1):326-37. PubMed ID: 26755879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery approaches of gene therapy in hepatocellular carcinoma.
    Duan F; Lam MG
    Anticancer Res; 2013 Nov; 33(11):4711-8. PubMed ID: 24222105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golgi membrane protein GP73 modified-liposome mediates the antitumor effect of survivin promoter-driven HSVtk in hepatocellular carcinoma.
    Liu C; Wen C; Wang X; Wei Y; Xu C; Mu X; Zhang L; Wang X; Tian J; Ma P; Meng F; Zhang Q; Zhao N; Yu B; Gong T; Guo R; Wang H; Xie J; Sun G; Li G; Zhang H; Qin Q; Xu J; Dong X; Wang L
    Exp Cell Res; 2019 Oct; 383(1):111496. PubMed ID: 31306654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in liver-directed gene transfer vectors.
    Xia D; Zhang MM; Yan LN
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):332-6. PubMed ID: 15313663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma.
    Khan N; Bammidi S; Chattopadhyay S; Jayandharan GR
    Bioconjug Chem; 2019 Jun; 30(6):1754-1762. PubMed ID: 31181889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated gene transfer to orthotopic hepatocellular carcinomas in athymic nude mice.
    Yoon SK; Armentano D; Wands JR; Mohr L
    Cancer Gene Ther; 2001 Aug; 8(8):573-9. PubMed ID: 11571535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.
    Urnauer S; Klutz K; Grünwald GK; Morys S; Schwenk N; Zach C; Gildehaus FJ; Rödl W; Ogris M; Wagner E; Spitzweg C
    J Gene Med; 2017 May; 19(5):. PubMed ID: 28423213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice.
    Mohr L; Yoon SK; Eastman SJ; Chu Q; Scheule RK; Scaglioni PP; Geissler M; Heintges T; Blum HE; Wands JR
    Hum Gene Ther; 2001 May; 12(7):799-809. PubMed ID: 11339896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles as cancer-specific DNA delivery vectors to human hepatocellular carcinoma.
    Zamboni CG; Kozielski KL; Vaughan HJ; Nakata MM; Kim J; Higgins LJ; Pomper MG; Green JJ
    J Control Release; 2017 Oct; 263():18-28. PubMed ID: 28351668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Description of CRISPR/Cas9 development and its prospect in hepatocellular carcinoma treatment.
    Wu X; Ma W; Mei C; Chen X; Yao Y; Liu Y; Qin X; Yuan Y
    J Exp Clin Cancer Res; 2020 Jun; 39(1):97. PubMed ID: 32487115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy.
    Xiao X; He Q; Huang K
    Med Oncol; 2010 Dec; 27(4):1200-7. PubMed ID: 19949900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV Infection: Protection from Cancer.
    Srivastava A; Carter BJ
    Hum Gene Ther; 2017 Apr; 28(4):323-327. PubMed ID: 27832705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of hepatocellular carcinoma.
    Ruiz J; Mazzolini G; Sangro B; Qian C; Prieto J
    Dig Dis; 2001; 19(4):324-32. PubMed ID: 11935092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer.
    Harada Y; Iwai M; Tanaka S; Okanoue T; Kashima K; Maruyama-Tabata H; Hirai H; Satoh E; Imanishi J; Mazda O
    Cancer Gene Ther; 2000 Jan; 7(1):27-36. PubMed ID: 10678353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy.
    Chandler RJ; LaFave MC; Varshney GK; Trivedi NS; Carrillo-Carrasco N; Senac JS; Wu W; Hoffmann V; Elkahloun AG; Burgess SM; Venditti CP
    J Clin Invest; 2015 Feb; 125(2):870-80. PubMed ID: 25607839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.